Abstract
The effects of CGS 13080, a thromboxane (TXA2) synthase inhibitor, on airway responses to arachidonic acid (AA) were investigated in the anesthetized cat. Feline and human lung microsomal fraction exhibited prostaglandin I2 (PGI2, prostacyclin), and TXA2 synthase activities, and human platelet microsomal fractions exhibited TXA2 synthase activity. Cat and human lung microsomal fractions, but not human platelets, exhibited the presence of GSH-dependent PGE2 isomerase activity. CGS 13080 inhibited TXA2 synthase activity in all three microsomal fractions in a concentration-dependent manner. The increases in transpulmonary pressure and lung resistance and decreases in dynamic compliance in response to AA were decreased significantly by CGS 13080. These data suggest that the bronchoconstrictor actions of AA are mediated in large part by the formation of TXA2. The data further indicate that cyclooxygenase products other than TXA2 are involved in the bronchoconstrictor response to AA since meclofenamate had greater inhibitory activity than did CGS 13080. Moreover, the effects of CGS 13080 were due to inhibition of TXA2 synthase rather than an effect on TXA2 receptors, since airway responses to the TXA2 mimic, U46619, were not altered. The present data show that CGS 13080 inhibits TXA2 synthase activity without altering cyclooxygenase, PGI2 synthase, or GSH-dependent PGE2 isomerase activities. The data further indicate that in vivo administration of CGS 13080 may selectively increase PGI2 synthase activity.
Similar content being viewed by others
References
Kadowitz PJ, Hyman AL: Influence of a prostaglandin endoperoxide analogue on the canine pulmonary vascular bed. Circ Res 40:282–287, 1977
Kadowitz PJ, Chapnick BM, Feigen LP, Hyman AL, Nelson PK, Spannhake E W. Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2. J Appl Physiol 45:408–413, 1978
Levin JL, Spannhake EW, Hyman AL, Kadowitz PJ: Analysis of airway responses to dihomo-γ-linolenic acid in the cat. J Pharmacol Exp Ther 223:169–176, 1982
Spannhake EW, Lemen RJ, Wegmann MJ, Hyman AL, Kadowitz PJ: Effects of arachidonic acid and prostaglandins on lung function in the intact dog. J Appl Physiol 44:397–495, 1978
Spannhake EW Levin JL, Mellion BT, Gruetter CA, Hyman AL, Kadowitz PJ: Reversal of 5-HT-induced bronchoconstriction by PGI2. Distribution of central and peripheral actions. J Appl Physiol 49:521–527, 1980
She HS, McNamara D, Spannhake EW, Hyman AL, Kadowitz PJ: Metabolism of prostaglandin endoperoxide by microsomes from cat lung. Prostaglandins 21:531–541, 1981
Wasserman MA, DuCharme DW, Griffin RL, De Graff GL, Robinson FG: Bronchopulmonary and cardiovascular effects of prostaglandin D2 in the dog. Prostaglandins 13:255–265, 1977
Bhagwat SS, Hamann PR, Still WC, Bunting S, Fitzpatrick FA: Synthesis and structure of the platelet aggregating factor thromboxane A2. Nature 315:511–513, 1985
Dahlen SE: Pulmonary effects of leukotrienes. Acta Physiol Scand 512:1–10, 1983
Graybar GB, Harrington JK, Cowen KH, Spannhake EW, Hyman AL, McNamara DB, Kadowitz PJ: Cyclooxygenase mediated airway response to leukotriene D4 in the cat. Prostaglandins 31:167–177, 1986
Kadowitz PJ, Hyman AL: Analysis of responses to leukotriene D4 in the pulmonary vascular bed. Ore Res 55:707–717, 1984
Demling RH, Smith M, Gunther R, Flynn JT, Gee M: Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep. Am J Physiol 240:H348-H353, 1981
Dusting GJ, Moncada S, Vane JR: Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory roles in normal and abnormal circulatory systems. Prog Cardiovasc Dis 21:405–414, 1979
Hales CA, Stonne L, Peterson M, Kong D, Miller M, Walkens WD: Role of thromboxane and prostacyclin in pulmonary vasomotor changes after endotoxin in dogs. J Clin Invest 68:497–505, 1981
Moncada S, Vane JR: Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Res 30:293–323, 1979
Piper P, Vane JR: The release of prostaglandins from lung and other tissue. Ann NY Acad Sci 180:363–385, 1981
Spannhake EW, Colombo JL, Craigo PA, McNamara DB, Hyman AL, Kadowitz PJ: Evidence for modification of pulmonary cyclooxygenase activity by endotoxin in the dog. J Appl Physiol 54:191–198, 1983
Wise WC, Cook JA, Haluska PW napp DP: Protective effects of thromboxane synthetase inhibitors in rats in endotoxis shock. Circ Res 46:854–859, 1980
Bertele U, De Gaetano G: Potentiation by dazoxiben, a thromboxane synthetase inhibitor of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin. Eur J Pharmacol 85:331–333, 1982
Burke SE, Di Cola G, Lefer AM: Protection of ischemic cat myocardium by CGS 13080, a selective potent thromboxane A2 synthesis inhibitor. J Cardiovasc Pharmacol 5:842–847, 1983
Ku EC, McPherson SE, Signor C, Chertock H, Cash WD: Characterization of imidazo(1,5-a)pyridine-5 hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models. Biochem Biophys Res Comm 112:899–906, 1983
Nadel JA, Tierney DF: Effect of a previous deep respiration on airway resistance in man. J Appl Physiol 16:717–719, 1961
Kerstein MD, Saroyan M, McMullen-Laird M, Hyman AL, Kadowitz PJ, McNamara D: Metabolism of prostaglandins in human saphenous vein. J Surg Res 35:91–100, 1983
Coleman RA, Humphrey PPA, Kennedy I, Levy GP, Lumley P: Comparison of the actions of U46619, a prostaglandin H2 analog, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol 73:773–778, 1981
Hamberg M: On the formation of thromboxane B2 and 12L hydroxy-5,8,10,14-eicosatetracnoic acid (12 ho-20:4) in tissues from the guinea pig. Biochem Biophys Acta 431:651–654, 1976
Burgess JR, Rao K, Reddy C: Two electron reduction of prostaglandin endoperoxides to PGF2α by rat liver glutathione-S-transferases. Fed Proc 44:490, 1985
Christ-Hazelhof E, Nugteren DH, van Dorp DA: Conversions of prostaglandin endoperoxides by gluthathione-Stransferases and serum albumins. Biochim Biophys Acta 450:450–461, 1976
Ogino N, Miyamoto T, Yamamoto S, Hayaishi O: Prostaglandin endoperoxide E isomerase from bovine vesicular gland microsomes, a glutathione requiring enzyme. J Biol Chem 252:890–895, 1977
Shimizu T, Yamamoto S, Hayaishi O: Purification and properties of prostaglandin D synthetase from rat brain. J Biol Chem 254:5222–5228, 1979
Christ-Hazelhof E, Nugteren DH: Purification and characterization of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzyme. Biochem Biophys Acta 572:43–51, 1979
Sun FF: Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane synthetase. Biochem Biophys Res Comm 74:1432–1440, 1977
Akers DL, Kerstein MD, Rush DS, Bellan JA, Haynes DF, Kadowitz PJ, McNamara DB: Prostacyclin and thromboxane A2 formation by atherosclerotic carotid artery: comparison with normal aorta, saphenous vein and platelets. J Vasc Surg (accepted), 1988
Meister A, Anderson ME: Glutathione. Ann Rev Biochem 52:711–760, 1983
McNamara DB, Hussey JL, Kerstein MD, Rosenson Rs, Hyman AL, Kadowitz PJ: Modulation of prostacyclin synthetase and unmasking of PGE2 isomerase in bovine coronary arterial microsomes. Biochem Biophys Res Comm 118:33–39, 1984
McNamara DB, Rush DS, Kerstein MD, Bellan JA, Mayeux PR, Adinolfi MF, Hyman AL, Kadowitz PJ: Prostaglandin endoperoxide metabolism by the human carotid artery. In: RE Beamish, V Pannagia and NS Dhalla (eds) Pathogenesis of Stress-Induced Heart Disease. Martinus Nijhoff Publ, Boston, 1985, pp 333–341
Rush DS, Kerstein MD, Bellan JA, Knoop SM, Mayeux PR, Hyman AL, Kadowitz PJ, McNamara DB: Prostacyclin, thromboxane A2 and prostaglandin E2 formation in atherosclerotic human carotid artery. Arteriosclerosis 8:73–78, 1988
Kerstein M, Kadowitz P, Hyman A, McNamara DB: Prostaglandin endoperoxide metabolism in normal pulmonary tissue from malignant and non-malignant lung. Am Rev Respir Dis 131:A394, 1985
McNamara DB, Laird M, Hyman AL, Kadowitz PJ, Cassin S: Prostaglandin H2 metabolism by fetal, newborn and adult goat lung. Fed Proc 41:1251, 1982
Raz A, Aharony D: Prostaglandin biosynthesis in platelets: demonstration and role of prostaglandin H2 → E2 isomerase. Res Comm Pathol Pharmacol 21:507–515, 1978
Bellan JA, Cassin S, Kerstein MD, Rush DL, Hyman AL, Kadowitz PJ, McNamara DB: Pulmonary prostaglandin endoperoxide (PGH2) metabolism in the fetal, 8-day neonatal and adult goat. Circulation 74:11–89, 1986
Tod ML, Cassin S: Thromboxane synthetase inhibition and perinatal pulmonary responses to arachidonic acid. J Appl Physiol 58:710–716, 1985
Spannhake EW, Hyman AL, Kadowitz PJ: Bronchoactive metabolites of arachidonic acid and their role in airway function. Prostaglandins 22:1013–1026, 1981
Underwood DC, Kriseman T, McNamara DB, Hyman AL, Kadowitz PJ: Blockade of thromboxane responses in the airway of the cat by SQ 29,548. J Appl Physiol 62:2193–2200, 1987
Tilden SJ, Underwood DC, Cowen KH, Wegmann MJ, Graybar GB, Hyman AL, McNamara DB, Kadowitz PJ: Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PHH2. J Appl Physiol 62:2066–2074, 1987
Burch RM, Mais DE, Saussy DL Jr, Halushka PU: Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets. Proc Nat Acad Sci 82:7434–7438, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McNamara, D.B., Harrington, J.K., Bellan, J.A. et al. Inhibition of pulmonary thromboxane A2 synthase activity and airway responses by CGS 13080. Mol Cell Biochem 85, 29–41 (1989). https://doi.org/10.1007/BF00223511
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00223511